Evonik Oxeno

Evonik Oxeno, a wholly-owned subsidiary of Evonik, is a leading company in C4 chemistry with 50 years of experience, operating two world-scale C4 production facilities in Marl and Antwerp. The flexibility of its integrated network allows Oxeno to quickly and efficiently respond to changing conditions in supply and demand, optimizing the complexity of value chains also for its suppliers and customers. Oxeno is recognized for its focus on innovation and sustainability, maintaining an impressive portfolio of approximately 2,500 patents and patent applications. Its C4 strategy is based on a solid foundation and defined measures for growth and transformation. The company's vision, "Chemistry4Future® – We increase the value of C4 chemicals sustainably," outlines its long-term goal and provides a clear idea of where it aims to see its business in the future.

Our products improve the properties of rubbers, plastics, adhesives, fuels and more: 1,2-Butadiene, 1,3-Butadiene, 2-PH, Butene-1, C4 Oligomers, Diisobutene, DRIVERON® S and T, DRIVOSOL®, ELATUR® CH, ELATUR® DINCD, ELATUR® DPT, ELATUR® TM, ELUCARE® TD, Isobutane, Isobutene, Isononanol, MTBE, n-Butan, Oxo Oils, OxoPhos®, TBA, TMH, VESTINOL® 9 and VESTOPLAST®.